Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2002, p. 2038-2040, Vol. 46, No. 6
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.6.2038-2040.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Abteilung Parasitologie, Hygiene-Institut,1 Institut für Pharmazeutische Biologie, Ruprecht-Karls-Universität, Heidelberg, Germany2
Received 15 October 2001/ Returned for modification 27 November 2001/ Accepted 20 March 2002
Seven peptidyl proteasome inhibitors were tested for in vitro activity against Trypanosoma brucei bloodstream forms. Two compounds showed activity in the low nanomolar range. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential of proteasome inhibitors for rational antitrypanosomal drug development.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»